Evom AI raises seed bridge funding from Kkeullim Ventures to advance heart disease-focused AI solutions.
Round Type
Seed
SeoulBiotechnologyHealth CareArtificial IntelligenceInvestors
Description
Medical AI startup Evom AI has raised seed bridge funding to enhance their heart disease-focused AI products. This funding will help accelerate upgrades and commercialisation efforts. They are also moving beyond the research stage, ready to supply products to medical settings. The company's recent certification supports their expansion plans in cardiac AI.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Evom AI that raised within 45 days of this round, from Fundz verified event records.
- Safe Superintelligence raised $3B (Convertible Note) on July 27, 2026.
- TidalSense raised $19M on July 24, 2026.
- InnoDtech raised $3.4M (Seed) on July 23, 2026.
- Transcripta Bio raised $24M (Series A) on July 22, 2026.
- mediworkAI raised an undisclosed amount on July 21, 2026.
- Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
Who to call at Evom AI, and when
A new round usually means Evom AI is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Evom AI raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Evom AI, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Evom AI. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Evom AI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Evom AI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.